Bovero Andrea, Opezzo Marta, Tesio Valentina
Clinical Psychology Unit, AOU Città della Salute e della Scienza, Turin, Italy.
Department of Psychology, University of Turin, Turin, Italy.
Psychooncology. 2023 Mar;32(3):429-437. doi: 10.1002/pon.6095. Epub 2023 Jan 11.
To examine the relationship between demoralization and health-related quality of life (HRQoL) in a sample of end-of-life cancer patients with a life expectancy of 4 months or less undergoing palliative care, controlling for sociodemographic, clinical, and psychological variables.
Sociodemographic, clinical, and psychological data from 170 end-of-life cancer patients were collected using the following scales: Edmonton Symptom Assessment System for palliative care patients' symptoms; Patient Health Questionnaire-9 (PHQ-9) for depressive symptoms; Functional Assessment of Cancer Therapy Scale - General Measure (FACT-G) for HRQoL; Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being for spirituality (FACIT-Sp); Demoralization Scale - Italian Version (DS-IT) for demoralization.
The DS-IT showed that 51.8% of cancer patients were severely demoralized. In addition, 36.5% of the sample had clinically significant depressive symptoms and QoL was severely impaired (FACT-G). The result of regression analysis showed that demoralization (especially "Disheartenment" and "Sense of failure") was the strongest contributor for HRQoL, followed by ESAS_Lack of Well-Being and depression (PHQ-9), with the final model explaining 66% of the variance of the FACT-G.
The results highlight a very high prevalence of severe demoralization in end-of life cancer patients. Moreover, demoralization was not only associated with patients' HRQoL, but it was also the most important contributing factor. This finding underscores the need to identify preventive or therapeutic psychological interventions that focus on preventing existential distress, and thus improve the QoL of dying patients in their last days of life.
在预期寿命为4个月或更短且正在接受姑息治疗的临终癌症患者样本中,研究士气低落与健康相关生活质量(HRQoL)之间的关系,同时控制社会人口统计学、临床和心理变量。
使用以下量表收集了170名临终癌症患者的社会人口统计学、临床和心理数据:用于评估姑息治疗患者症状的埃德蒙顿症状评估系统;用于评估抑郁症状的患者健康问卷-9(PHQ-9);用于评估HRQoL的癌症治疗功能评估量表-通用版(FACT-G);用于评估精神性的慢性病治疗功能评估-精神幸福感量表(FACIT-Sp);用于评估士气低落的士气低落量表-意大利语版(DS-IT)。
DS-IT显示,51.8%的癌症患者士气严重低落。此外,36.5%的样本有临床上显著的抑郁症状,生活质量严重受损(FACT-G)。回归分析结果表明,士气低落(尤其是“沮丧”和“失败感”)是HRQoL的最强影响因素,其次是埃德蒙顿症状评估系统中的幸福感缺乏和抑郁(PHQ-9),最终模型解释了FACT-G变异的66%。
研究结果凸显了临终癌症患者中严重士气低落的高患病率。此外,士气低落不仅与患者的HRQoL相关,而且是最重要的影响因素。这一发现强调了识别侧重于预防生存痛苦从而改善临终患者最后日子生活质量的预防性或治疗性心理干预措施的必要性。